Bio-Rad Laboratories

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$592,100
$693,200
$653,000
$651,600
Gross Profit
309,400
345,200
343,400
345,300
EBITDA
-677,500
114,300
120,600
477,200
EBIT
61,900
66,400
426,600
Net Income
-527,100
720,000
-341,900
317,800
Net Change In Cash
592,100
693,200
653,000
651,600
Free Cash Flow
78,100
119,100
89,200
70,800
Cash
507,200
531,799
397,800
369,300
Basic Shares
26,958
27,012
26,923
27,228

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,583,200
$2,566,500
$2,671,262
$2,802,249
Gross Profit
1,343,600
1,378,900
1,426,946
1,567,330
EBITDA
475,900
-2,142,000
-654,800
-4,488,959
EBIT
270,500
-2,293,600
-800,700
-4,666,159
Net Income
759,900
-1,844,200
-637,324
-3,627,535
Net Change In Cash
2,583,200
2,566,500
2,671,262
2,802,249
Cost of Revenue
-39,570
Free Cash Flow
374,600
266,200
218,263
80,290
Cash
531,799
488,100
403,800
434,215
Basic Shares
27,281
28,214
29,209
29,785

Earnings Calls

QuarterEPS
2026-03-31
$1.89
2025-12-31
$2.51
2025-09-30
$2.26
2025-06-30
$2.61